CIPLA the Indian pill company is midway between Canada and Australia, our intrepid leader PB can take a break and go see the taj mahal,
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
